Related content

IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy

By                    

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1325-1336

Spandidos Publications

Access to resources Recommend Favorite

Apoptotic Index in Ovarian Carcinoma: Correlation with Clinicopathologic Factors and Prognosis

By Yamasaki F.   Tokunaga O.   Sugimori H.  

Gynecologic Oncology, Vol. 66, Iss. 3, 1997-09 ,pp. : 439-448

Elsevier

Access to resources Recommend Favorite

IDH1 mutation of gliomas with long-term survival analysis

By Myung Jae Kyung   Cho Hwa Jin   Park Chul-Kee   Kim Seung-Ki   Phi Ji Hoon   Park Sung-Hye  

Oncology Reports, Vol. 28, Iss. 5, 2012-11 ,pp. : 1639-1644

Spandidos Publications

Access to resources Recommend Favorite

cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome

By Odia Yazmin   Orr Brent   Robert Bell W.   Eberhart Charles   Rodriguez Fausto  

Journal of Neuro-Oncology, Vol. 115, Iss. 2, 2013-11 ,pp. : 249-259

Springer Publishing Company

Access to resources Recommend Favorite

Factors affecting prognosis of patients with intracranial anaplastic oligodendrogliomas: a single institutional review of 70 patients

By Yang Liu-song   Huang Feng-ping   Zheng Kang   Zhang Hai-shi   Zhou Xiang   Bao Xu-hui   Zheng Jia-jun   Chang Chuan   Zhou Liang-fu  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 113-120

Springer Publishing Company

Access to resources Recommend Favorite